At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...